GLP-1s Linked to Increased Risk of Bone and Joint Disorders
Stock image of a man with a castCredit: Getty NEED TO KNOW New research has found that GLP-1…
Fridge left ajar as £25k of SaTH meds ‘written off’
NHS trust leaders heard that the fridge in The Shrewsbury and Telford Hospital NHS Trust pharmacy department did…
Study links heavy metals, ‘hidden drugs’ in alt meds to liver injury. Safety, regulation debate grows
Published in Frontiers in Gastroenterology—an open-access research in digestive health, liver disease, infections, cancer and gastrointestinal care—the study…
Fatal ‘power to harm’ warning issued to people who use Ibuprofen, aspirin and naproxen
Experts have issued a crucial warning for anyone who takes Ibuprofen, aspirin and naproxen – and have outlined…
NAFDAC warns public over fake avastin injection in circulation
The National Agency for Food and Drug Administration and Control, NAFDAC, has raised an alert over the circulation…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Ozempic Maker Sued After Woman Died From Stomach Paralysis
The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after…
Delaware approves $200 copay for weight-loss drugs
Why Should Delaware Care?Delaware began to cover commercial weight-loss drugs like Ozempic and Wegovy for state employees as…
NHS tip for getting ‘quick’ repeat prescription ‘whenever it suits you’
Anyone with a repeat prescription could benefit from the recommendation shared by the NHS NHS patients can use…
GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest
GLP-1 medications such as Ozempic and Wegovy have transformed treatment for Type 2 diabetes and obesity, but new…
FDA under scrutiny: 4 issues facing beleaguered agency
The U.S. Food and Drug Administration (FDA) has faced an unusual convergence of political, scientific, legal and operational…
DCGI cracks down on indirect promotion of weight-loss prescription drugs
New Delhi: The Drugs Controller General of India (DCGI) has directed all pharmaceutical manufacturers and importers to immediately…